Plain-English translation of NCT06758128 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why some people's heart failure gets worse and what role inflammation and genetics play in this. This study will collect blood samples from about 215 patients hospitalized with heart failure to measure inflammation markers and study immune cells. By learning more about these patterns, especially in older adults and across different genders, doctors hope to eventually develop better ways to predict and prevent heart failure flare-ups.
Heart failure is a serious condition that affects millions of people worldwide, and doctors don't fully understand why some patients experience sudden worsening of their symptoms while others remain stable. This research aims to identify biological markers of inflammation that could help predict who is at higher risk for complications, potentially leading to better treatments and prevention strategies in the future.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be cared for as normal during your hospital stay for heart failure. Doctors will collect routine information about your condition, symptoms, and medical history from your hospital records. During one of your regular blood draws, researchers will collect one additional blood sample for special testing of inflammation markers and immune cells. The study doesn't require extra visits or procedures beyond standard care.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Italy